{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T02:10:21Z","timestamp":1759025421652,"version":"3.44.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jad.2020.12.128","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T11:52:00Z","timestamp":1609156320000},"page":"126-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Depression in patients with chronic hepatitis-C treated with direct-acting antivirals: A real-world prospective observational study"],"prefix":"10.1016","volume":"282","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6115-6100","authenticated-orcid":false,"given":"Mohamed A.","family":"Khalil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0928-4738","authenticated-orcid":false,"given":"Hend Ibrahim","family":"Shousha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed M.","family":"El-Nahaas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Ibrahim","family":"Negm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4056-3847","authenticated-orcid":false,"given":"Kariman","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagwan Mohamed","family":"Madbouly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2020.12.128_bib0001","doi-asserted-by":"crossref","unstructured":"Abdel-Khalek, A.M. (1998). Internal consistency of an Arabic adaptation of the Beck depression inventory in four Arab countries, 82(1), 264-266. doi:10.2466\/pr0.1998.82.1.264. PMID: 9520563.","DOI":"10.2466\/pr0.1998.82.1.264"},{"issue":"6","key":"10.1016\/j.jad.2020.12.128_bib0002","article-title":"Correction of the modified symptom list SCL-90-R on a sample of students from the University of Taibah","volume":"2","author":"Baqaiee","year":"2018","journal-title":"J. Educ. Psychol. Sci."},{"issue":"5","key":"10.1016\/j.jad.2020.12.128_bib0003","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000348587","article-title":"A biopsychosocial model of interferon-alpha-induced depression in patients with chronic hepatitis C infection","volume":"82","author":"Baranyi","year":"2013","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"6","key":"10.1016\/j.jad.2020.12.128_bib0004","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"Beck depression inventory (BDI)","volume":"4","author":"Beck","year":"1961","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2020.12.128_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psym.2016.09.004","article-title":"Hepatitis C treatment: clinical issues for psychiatrists in the post-interferon era","volume":"58","author":"Chasser","year":"2017","journal-title":"Psychosomatics"},{"issue":"6","key":"10.1016\/j.jad.2020.12.128_bib0006","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.phrp.2016.11.001","article-title":"Illness experience of patients with chronic hepatitis C participating in clinical trials.","volume":"7","author":"Cho","year":"2016","journal-title":"Osong Public Health Res. Perspect."},{"year":"1992","series-title":"SCL-90-R: Administration, Scoring & Procedures Manual-II, for the R (Revised) Version and Other Instruments of the Psychopathology Rating Scale Series","author":"Derogatis","key":"10.1016\/j.jad.2020.12.128_bib0007"},{"issue":"1","key":"10.1016\/j.jad.2020.12.128_bib0008","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1590\/1516-4446-2018-0336","article-title":"Incidence of depression in patients with hepatitis C treated with direct-acting antivirals","volume":"42","author":"Egmond","year":"2020","journal-title":"Revista Brasileira de Psiquiatria"},{"issue":"4","key":"10.1016\/j.jad.2020.12.128_bib0009","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/jvh.12668","article-title":"National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care","volume":"24","author":"El-Akel","year":"2017","journal-title":"Journal of Viral Hepatitis"},{"issue":"4","key":"10.1016\/j.jad.2020.12.128_bib0010","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/liv.13266","article-title":"Real life Egyptian experience of efficacy and safety of Simeprevir\/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients","volume":"37","author":"Eletreby","year":"2017","journal-title":"Liver International: Official Journal of the International Association for the Study of the Liver"},{"issue":"5","key":"10.1016\/j.jad.2020.12.128_bib0011","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/apt.13923","article-title":"Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt","volume":"45","author":"Elsharkawy","year":"2017","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1016\/j.jad.2020.12.128_bib0012","doi-asserted-by":"crossref","unstructured":"European Association for Study of Liver (2015). EASL recommendations on treatment of hepatitis C 2015. J. Hepatol., 63(1), 199\u2013236. doi: 10.1016\/j.jhep.2015.03.025.","DOI":"10.1016\/j.jhep.2015.03.025"},{"year":"1994","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I)","author":"First","key":"10.1016\/j.jad.2020.12.128_bib0013"},{"issue":"12","key":"10.1016\/j.jad.2020.12.128_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208112","article-title":"Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C","volume":"13","author":"Gallach","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jad.2020.12.128_bib0015","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus","volume":"61","author":"Gower","year":"2014","journal-title":"J. Hepatol."},{"year":"2004","series-title":"Dual Diagnosis in Substance Abuse, a Study in an Egyptian Sample","author":"Hatata","key":"10.1016\/j.jad.2020.12.128_bib0016"},{"year":"2011","series-title":"IBM SPSS Statistics for Windows (Version 20.0)","key":"10.1016\/j.jad.2020.12.128_bib0017"},{"issue":"6","key":"10.1016\/j.jad.2020.12.128_bib0018","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1007\/s12035-018-1359-3","article-title":"Neuroimmunomodulation in major depressive disorder: focus on Caspase 1, inducible nitric oxide synthase, and interferon-gamma","volume":"56","author":"Inserra","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.jad.2020.12.128_bib0019","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1111\/1475-6773.12758","article-title":"A randomized trial of off-site collaborative care for depression in chronic hepatitis C virus","volume":"53","author":"Kanwal","year":"2018","journal-title":"Health Services Research"},{"issue":"3","key":"10.1016\/j.jad.2020.12.128_bib0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/ejhpharm-2017-001352","article-title":"New direct-acting antivirals for hepatitis C treatment and neuropsychiatric symptoms in psychiatric risk groups","volume":"26","author":"Miarons","year":"2019","journal-title":"Eur. J. Hosp. Pharm.: Sci. Pract."},{"issue":"6","key":"10.1016\/j.jad.2020.12.128_bib0021","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/liv.13102","article-title":"Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function","volume":"36","author":"Saxena","year":"2016","journal-title":"Liver International: Official Journal of the International Association for the Study of the Liver"},{"key":"10.1016\/j.jad.2020.12.128_bib0022","article-title":"Simple predictors of nonresponse to direct-acting antivirals in chronic hepatitis C patients","author":"Shousha","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatolol."},{"key":"10.1016\/j.jad.2020.12.128_bib0023","article-title":"Assessment of facility performance during mass treatment of chronic hepatitis C in Egypt: Enablers and obstacles","volume":"27","author":"Shousha","year":"2020","journal-title":"Journal of Infection and Public Health"},{"issue":"Suppl 11","key":"10.1016\/j.jad.2020.12.128_bib0024","first-page":"S454","volume":"63","author":"Smarr","year":"2011","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jad.2020.12.128_bib0025","series-title":"Liver Research and Clinical Management","first-page":"203","article-title":"Neurocognitive impairments and depression and their relationship to hepatitis C virus infection","author":"Stanculete","year":"2018"},{"issue":"6","key":"10.1016\/j.jad.2020.12.128_bib0026","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1","key":"10.1016\/j.jad.2020.12.128_bib0027","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12888-018-1735-6","article-title":"Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study","volume":"18","author":"Sundberg","year":"2018","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2020.12.128_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.571166","article-title":"Reversal of immunity after clearance of chronic HCV infection - all reset?","volume":"11","author":"Wedemeyer","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jad.2020.12.128_bib0029","unstructured":"World Health Organization (2016). Global health sector strategy on viral hepatitis 2016 \u2013 2021. Available from: http:\/\/www.who.int\/hepatitis\/strategy2016-2021\/ghss-hep\/en\/."},{"issue":"6","key":"10.1016\/j.jad.2020.12.128_bib0030","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/apt.13090","article-title":"Systematic review: patient-reported outcomes in chronic hepatitis C\u2013the impact of liver disease and new treatment regimens","volume":"41","author":"Younossi","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.jad.2020.12.128_bib0031","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/apt.13269","article-title":"The patient\u2019s journey with chronic hepatitis C from interferon plus ribavirin to interferon- and ribavirin-free regimens: a study of health-related quality of life","volume":"42","author":"Younossi","year":"2015","journal-title":"Aliment. Pharmacol. Ther."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720332183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720332183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:48:53Z","timestamp":1759024133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032720332183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":31,"alternative-id":["S0165032720332183"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2020.12.128","relation":{},"ISSN":["0165-0327"],"issn-type":[{"type":"print","value":"0165-0327"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depression in patients with chronic hepatitis-C treated with direct-acting antivirals: A real-world prospective observational study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2020.12.128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}